Pharmaceutical Contract Manufacturing Organization

Renaissance develops and manufactures high-quality pharmaceuticals to fulfill your patients’ needs.

Your Partner for Nasal Sprays

State-of-the-art laboratory

Cutting edge spray characterization instruments, almost 20 years in nasal experience, and successful commercialization of products for the US and global markets, Renaissance is the “one-stop-shop” for all your nasal spray formulation, development, testing, and commercialization needs.

LEARN MORE

Trusted, Reliable Contract Manufacturing

World-class sterile liquid manufacturing

Renaissance is a global, pure-play contract development and manufacturing organization (“CDMO”) leader with an unparalleled bench-to-shelf service offering for nasal and sterile injectable dosage forms.

LEARN MORE

1979

Where it all started. Paco Packaging & Labs relocates to Paco Way in Lakewood, NJ from Philadelphia, PA.

LEARN MORE
pharmaceutical vials on assembly line
Trusted & Reliable Manufacturing

Our Capabilities Overview

Watch Video

News & Events

Our newest offerings and capabilities. Recent investments in our facilities, new and expanded services and expertise. Upcoming conferences and events.
Insights

April 24, 2025

Repositioning approved therapies as nasal sprays

Nasal spray repositioning through the 505(b)(2) regulatory pathway has emerged as a compelling approach, offering a unique opportunity to breathe new life into existing drugs and improve patient experiences.

READ MORE
Events

January 28, 2025

DCAT Week

March 17th – March 20th in New York City. The Premier Event for the Global Bio/Pharmaceutical Manufacturing Value Chain

READ MORE
Events

January 28, 2025

Nasal Formulation & Delivery Summit

The 3rd Nasal Formulation & Delivery Summit will unite biotechs and innovate start-ups to share case studies and best practices in optimizing nasal drug delivery across different therapeutic areas.

READ MORE

+$30m

+$30 million in facilities and equipment investments since 2020

1st

Manufacturer of the first FDA approved bi-dose nasal spray drug

310k

Sq. ft. of infrastructure with additional space under construction

+10

cGMP manufacturing suites with additional under construction